S100A9 and psoriasis: Immunofluorescence analysis demonstrated that secukinumab effectively suppressed the M5-induced upregulation of psoriasis-related markers, including KRT17, S100A7, S100A9, and HK2, in HaCaT cells [Fig. 8(l)].